secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0000950170-25-078375
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OnKure shareholders elect Manke and Saccomano as Class I directors, ratify KPMG as auditor for FY2025
--------------------------------------------------------------------------------

- Dr. Isaac Manke elected with 4,589,481 for, 882,303 withheld; Dr. Nicholas Saccomano with 5,209,380 for, 262,404 withheld.
- KPMG LLP ratified as independent auditor for fiscal year ending December 31, 2025 (6,750,408 for, 111,715 against, 208 abstain).
- Both directors will serve until the 2028 annual meeting of stockholders.
- Broker non-votes totaled 1,390,547 for each director proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000095017025078375/0000950170-25-078375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000095017025078375/okur-20250527.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-078375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer